MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease

Author: D'Andrea M.R.   Nagele R.G.  

Publisher: Informa Healthcare

ISSN: 1473-7760

Source: Biotechnic & Histochemistry, Vol.77, Iss.2, 2002-03, pp. : 95-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract